Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

T cell immunity and immunosuppression in cancer

Latest publications

Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species.

Journal article

Wesolowski AJ. et al, (2026), Science, 393, 1036 - 1044

Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.

Journal article

Conti AG. et al, (2026), Nat Immunol, 27, 436 - 451

Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity.

Journal article

Yang J. et al, (2025), Nature, 640, 1052 - 1061

IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.

Journal article

Imianowski CJ. et al, (2024), Cancer Res Commun, 4, 2045 - 2057

BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis.

Journal article

Imianowski CJ. et al, (2022), J Exp Med, 219

A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells.

Journal article

Nasrallah R. et al, (2020), Nature, 583, 447 - 452

IL-7-dependent maintenance of ILC3s is required for normal entry of lymphocytes into lymph nodes.

Journal article

Yang J. et al, (2018), J Exp Med, 215, 1069 - 1077